BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38186831)

  • 1. Radial nerve motor palsy after COVID vaccination: A case report.
    Radlberger RF; Trinka E; Leis S
    J Family Med Prim Care; 2023 Nov; 12(11):2967-2969. PubMed ID: 38186831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglossal nerve palsy after SARS-CoV-2 vaccination - report of two cases.
    Panholzer J; Kellermair L; Eggers C
    BMC Neurol; 2022 Nov; 22(1):416. PubMed ID: 36352369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines-A Case Series.
    Girbardt C; Busch C; Al-Sheikh M; Gunzinger JM; Invernizzi A; Xhepa A; Unterlauft JD; Rehak M
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.
    Battegay R; Istampoulouoglou I; Holbro A; Buser A; Hirsiger JR; Eckstein J; Berger CT; Koechlin S; Leuppi-Taegtmeyer AB
    Swiss Med Wkly; 2021 Dec; 151():w30084. PubMed ID: 34908388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythema multiforme following COVID-19 vaccination (BNT162b2)].
    Wunderlich K; Dirschka T
    Hautarzt; 2022 Jan; 73(1):68-70. PubMed ID: 34676438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
    Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
    J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Non-Severe Adverse Reactions after Vaccination against SARS-CoV-2: A Cohort Study of 908,869 Outpatient Vaccinations in Germany.
    Loosen SH; Bohlken J; Weber K; Konrad M; Luedde T; Roderburg C; Kostev K
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute facial paresis as a possible complication of vaccination against SARS-CoV-2].
    Volk GF; Kuttenreich AM; Geitner M; Guntinas-Lichius O
    Laryngorhinootologie; 2021 Jul; 100(7):526-528. PubMed ID: 33975372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated abducens nerve palsy following AstraZeneca vaccine: A case report.
    Basnet K; Bhandari R; Basnet K; Aryal A; Shrestha R
    Ann Med Surg (Lond); 2022 Sep; 81():104434. PubMed ID: 35999834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute abducens nerve palsy following COVID-19 vaccination.
    Reyes-Capo DP; Stevens SM; Cavuoto KM
    J AAPOS; 2021 Oct; 25(5):302-303. PubMed ID: 34044114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis after COVID-19 Comirnaty Vaccination: A Case Report.
    Ruijters VJ; van der Meulen MFG; van Es MA; Smit T; Hoogendijk JE
    Case Rep Neurol; 2022; 14(3):429-432. PubMed ID: 36636276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
    Neuhann JM; Stemler J; Carcas A; Frías-Iniesta J; Bethe U; Heringer S; Tischmann L; Zarrouk M; Cüppers A; König F; Posch M; Cornely OA
    Trials; 2022 Oct; 23(1):865. PubMed ID: 36209129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute abducens nerve palsy after COVID-19 vaccination in a young adult.
    Pawar N; Ravindran M; Padmavathy S; Chakrabarty S
    Indian J Ophthalmol; 2021 Dec; 69(12):3764-3766. PubMed ID: 34827043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Google Trends analysis confirm the public's need for information about the rare association of facial nerve paralysis with COVID-19 or the COVID-19 vaccination?
    Schubert R; Kaatz M; Schubert R; Springer S; Zieger M
    Rev Neurol (Paris); 2023 Mar; 179(3):218-222. PubMed ID: 36473747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study.
    Werner F; Zeschick N; Kühlein T; Steininger P; Überla K; Kaiser I; Sebastião M; Hueber S; Warkentin L
    BMC Med; 2023 Sep; 21(1):358. PubMed ID: 37726711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
    Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
    Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis.
    Pompsch M; Fisenkci N; Horn PA; Kraemer M; Lindemann M
    Neurol Res Pract; 2021 Nov; 3(1):60. PubMed ID: 34802469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.